Richard A. Young - 15 Oct 2024 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role
Director
Signature
By: /s/ Thomas Danielski, Attorney-in-Fact
Issuer symbol
CAMP
Transactions as of
15 Oct 2024
Net transactions value
$0
Form type
4
Filing time
15 Oct 2024, 17:46:10 UTC
Previous filing
10 Oct 2024
Next filing
27 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAMP Common Stock Conversion of derivative security +8,917 +6.1% 154,859 15 Oct 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAMP Series A Prime Preferred Stock Conversion of derivative security -100,014 -100% 0 15 Oct 2024 Common Stock 8,917 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering.